{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T19:47:44Z","timestamp":1790624864503,"version":"4.1.0"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"50","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Objective:<\/jats:title>\n            <jats:p>Several published studies have investigated the association between the \u2212308G\/A (rs1800629) polymorphism in the tumor necrosis factor-\u03b1 (<jats:italic toggle=\"yes\">TNF<\/jats:italic>-\u03b1) gene and the risk of dilated cardiomyopathy (DCM). However, the <jats:italic toggle=\"yes\">TNF<\/jats:italic>-\u03b1 gene polymorphism has a controversial role in the pathogenesis of DCM among different populations. In the present study, a meta-analysis was performed to resolve this inconsistency.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>Potentially eligible papers reporting an association between the <jats:italic toggle=\"yes\">TNF<\/jats:italic>-\u03b1 rs1800629 polymorphism and DCM susceptibility were searched in 4 databases including PubMed, EMBASE, Chinese Biomedical Database (CBM), and the Cochrane Library up to April 1, 2018. The odds ratio (OR) with its 95% confidence interval (CI) was used to estimate the strength of the associations. Subgroup analysis based on the ethnicity, studies with or without ischemic and valvular DCM was conducted. Publication bias detection was conducted using Begg test.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Nine papers detailing case-control studies were included, reporting a total of 1339 DCM cases and 1677 healthy controls. The meta-analysis results indicated that <jats:italic toggle=\"yes\">TNF<\/jats:italic>-\u03b1 rs1800629 was associated with increased DCM susceptibility in the populations studied under the heterozygous model (AG vs GG: OR\u200a=\u200a1.91, 95% CI\u200a=\u200a1.05\u22123.50, <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a.035) and dominant model (AG\u200a+\u200aAA vs GG: OR\u200a=\u200a1.87, 95% CI\u200a=\u200a1.01\u22123.45, <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a.046). In the subgroup analysis for ethnicity, rs1800629 polymorphism was significantly associated with the susceptibility of DCM for Asians under the 5 models (A vs G: OR\u200a=\u200a2.87, 95% CI\u200a=\u200a1.56\u22125.30, <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a.001; AA vs GG: OR\u200a=\u200a3.95, 95% CI\u200a=\u200a1.13\u221213.82, P\u200a=\u200a0.031; AG vs GG: OR\u200a=\u200a3.8, 95% CI\u200a=\u200a1.57\u22129.19, <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a.003; AA vs GG\u200a+\u200aAG: OR\u200a=\u200a2.51, 95% CI\u200a=\u200a1.41\u22124.49, <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a.002; AG\u200a+\u200aAA vs GG: OR\u200a=\u200a3.77, 95% CI\u200a=\u200a1.54\u22129.20, <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a.004).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>There may be a moderate association between <jats:italic toggle=\"yes\">TNF<\/jats:italic>-\u03b1 rs1800629 polymorphism and DCM susceptibility in the whole populations studied; however, <jats:italic toggle=\"yes\">TNF<\/jats:italic>-\u03b1 rs1800629 polymorphism was significantly associated with the susceptibility of DCM for Asians, which indicates that such associations may be different between ethnicities.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000013386","type":"journal-article","created":{"date-parts":[[2018,12,15]],"date-time":"2018-12-15T02:51:23Z","timestamp":1544842283000},"page":"e13386","source":"Crossref","is-referenced-by-count":10,"title":["Association between rs1800629 polymorphism in tumor necrosis factor-\u03b1 gene and dilated cardiomyopathy susceptibility"],"prefix":"10.1097","volume":"97","author":[{"given":"Yongdong","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhong","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linlin","family":"Xin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ningning","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingshuang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230914","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.trim.2008.01.001","article-title":"TNFalpha in patients with end-stage heart failure on medical therapy or supported by a left ventricular assist device","volume":"19","author":"Bruggink","year":"2008","journal-title":"Transpl Immunol"},{"key":"R2-20230914","first-page":"57","article-title":"Innate immune receptor activation in viral myocarditis: pathophysiologic implications","volume":"29","author":"Tavares","year":"2010","journal-title":"Rev Port Cardiol"},{"key":"R3-20230914","doi-asserted-by":"crossref","first-page":"2883","DOI":"10.1161\/01.CIR.0000100721.52503.85","article-title":"Noninvasive arrhythmia risk stratification in idiopathic dilated cardiomyopathy: results of the Marburg cardiomyopathy study","volume":"108","author":"Grimm","year":"2003","journal-title":"Circulation"},{"key":"R4-20230914","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0735-1097(99)00522-7","article-title":"Lack of association between polymorphisms of eight candidate genes and idiopathic dilated cardiomyopathy: the CARDIGENE study","volume":"35","author":"Tiret","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"R5-20230914","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1136\/hrt.73.5.417","article-title":"Familial dilated cardiomyopathy in the United Kingdom","volume":"73","author":"Keeling","year":"1995","journal-title":"Br Heart J"},{"key":"R6-20230914","doi-asserted-by":"crossref","first-page":"407","DOI":"10.5144\/0256-4947.2014.407","article-title":"Polymorphisms of tumor necrosis factor-alpha and interleukin-6 gene and C-reactive protein profiles in patients with idiopathic dilated cardiomyopathy","volume":"34","author":"Liaquat","year":"2014","journal-title":"Ann Saudi Med"},{"key":"R7-20230914","first-page":"1237","article-title":"Association between 22 cytokine gene polymorphisms and dilated cardiomyopathy in Macedonian patients","volume":"67","author":"Spiroska","year":"2009","journal-title":"Kardiol Pol"},{"key":"R8-20230914","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1161\/01.CIR.89.2.846","article-title":"Therapeutic effect of anti-tumor necrosis factor-alpha antibody on the murine model of viral myocarditis induced by encephalomyocarditis virus","volume":"89","author":"Yamada","year":"1994","journal-title":"Circulation"},{"key":"R9-20230914","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/sj.gene.6363898","article-title":"TNF-alpha promoter single nucleotide polymorphisms are markers of human ancestry","volume":"3","author":"Baena","year":"2002","journal-title":"Genes Immun"},{"key":"R10-20230914","doi-asserted-by":"crossref","first-page":"3195","DOI":"10.1073\/pnas.94.7.3195","article-title":"Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation","volume":"94","author":"Wilson","year":"1997","journal-title":"Proc Nat Acad Sci USA"},{"key":"R11-20230914","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1536\/jhj.41.183","article-title":"Polymorphisms of tumor necrosis factor-alpha and interleukin-10 genes in Japanese patients with idiopathic dilated cardiomyopathy","volume":"41","author":"Ito","year":"2000","journal-title":"Jpn Heart J"},{"key":"R12-20230914","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S1388-9842(02)00238-6","article-title":"Tumor necrosis factor-alpha polymorphism in Turkish patients with dilated cardiomyopathy","volume":"5","author":"Alikasifoglu","year":"2003","journal-title":"Eur J Heart Fail"},{"key":"R13-20230914","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1089\/dna.2012.1911","article-title":"Association of tumor necrosis factor-alpha gene G-308A polymorphism with dilated cardiomyopathy: a meta-analysis","volume":"32","author":"Luo","year":"2013","journal-title":"DNA Cell Biol"},{"key":"R14-20230914","doi-asserted-by":"crossref","first-page":"16","DOI":"10.4103\/0255-0857.148370","article-title":"Tumour necrosis factor-alpha promoter polymorphism and its association with viral dilated cardiomyopathy in Indian population: a pilot study","volume":"33","author":"Mishra","year":"2015","journal-title":"Indian J Med Microbiol"},{"key":"R15-20230914","doi-asserted-by":"crossref","first-page":"b2700","DOI":"10.1136\/bmj.b2700","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration","volume":"339","author":"Liberati","year":"2009","journal-title":"BMJ (Clin Res ed)"},{"key":"R16-20230914","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","article-title":"Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses","volume":"25","author":"Stang","year":"2010","journal-title":"Eur J Epidemiol"},{"key":"R17-20230914","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control Clin Trials"},{"key":"R18-20230914","first-page":"254","article-title":"The G-308A polymorphism of the TNF-alpha gene does not predict changes in cardiac function in response to medical therapy for idiopathic dilated cardiomyopathy","volume":"19","author":"Brooksbank","year":"2008","journal-title":"Cardiovasc J Africa"},{"key":"R19-20230914","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1089\/dna.2010.1044","article-title":"Association of tumor necrosis factor gene polymorphisms with susceptibility to dilated cardiomyopathy in a Han Chinese population","volume":"29","author":"Liang","year":"2010","journal-title":"DNA Cell Biol"},{"key":"R20-20230914","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1056\/NEJMoa021737","article-title":"The epidemiology of childhood cardiomyopathy in Australia","volume":"348","author":"Nugent","year":"2003","journal-title":"New Engl J Med"},{"key":"R21-20230914","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.cyto.2011.01.004","article-title":"Cytokine gene polymorphisms are associated with markers of disease severity and prognosis in patients with idiopathic dilated cardiomyopathy","volume":"54","author":"Adamopoulos","year":"2011","journal-title":"Cytokine"},{"key":"R22-20230914","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s10741-006-9196-2","article-title":"Systemic inflammation in heart failure\u2014the whys and wherefores","volume":"11","author":"Yndestad","year":"2006","journal-title":"Heart Fail Rev"},{"key":"R23-20230914","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/0167-5273(96)02607-1","article-title":"Tumour necrosis factor is expressed in cardiac tissues of patients with heart failure","volume":"54","author":"Doyama","year":"1996","journal-title":"Int J Cardiol"},{"key":"R24-20230914","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1161\/01.CIR.93.4.704","article-title":"Tumor necrosis factor-alpha and tumor necrosis factor receptors in the failing human heart","volume":"93","author":"Torre-Amione","year":"1996","journal-title":"Circulation"},{"key":"R25-20230914","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/S0735-1097(96)00567-0","article-title":"Inducible nitric oxide synthase and tumor necrosis factor-alpha in myocardium in human dilated cardiomyopathy","volume":"29","author":"Satoh","year":"1997","journal-title":"J Am Coll Cardiol"},{"key":"R26-20230914","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/S0008-6363(97)00309-X","article-title":"Tumor necrosis factor in CHF: a double facet cytokine","volume":"37","author":"Ferrari","year":"1998","journal-title":"Cardiovasc Res"},{"key":"R27-20230914","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1136\/heart.87.2.153","article-title":"Tumour necrosis factor alpha gene polymorphism: a predisposing factor to non-ischaemic myocardial dysfunction","volume":"87","author":"Densem","year":"2002","journal-title":"Heart (Br Cardiac Soc)"},{"key":"R28-20230914","first-page":"603","article-title":"Cytokine gene polymorphisms in childhood dilated cardiomyopathy: interferon- gamma, tumor necrosis factor-alpha and transforming growth factor\u2014beta 1 genes are associated with the disease in Turkish patients","volume":"23","author":"Balci","year":"2013","journal-title":"Iran J Pediatr"},{"key":"R29-20230914","doi-asserted-by":"crossref","first-page":"5456","DOI":"10.1073\/pnas.070036297","article-title":"Endogenous tumor necrosis factor protects the adult cardiac myocyte against ischemic-induced apoptosis in a murine model of acute myocardial infarction","volume":"97","author":"Kurrelmeyer","year":"2000","journal-title":"Proc Nat Acad Sci USA"},{"key":"R30-20230914","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1161\/01.CIR.97.14.1382","article-title":"Pathophysiologically relevant concentrations of tumor necrosis factor-alpha promote progressive left ventricular dysfunction and remodeling in rats","volume":"97","author":"Bozkurt","year":"1998","journal-title":"Circulation"},{"key":"R31-20230914","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1161\/01.CIR.99.11.1492","article-title":"Tissue expression and immunolocalization of tumor necrosis factor-alpha in postinfarction dysfunctional myocardium","volume":"99","author":"Irwin","year":"1999","journal-title":"Circulation"},{"key":"R32-20230914","doi-asserted-by":"crossref","first-page":"H743","DOI":"10.1152\/ajpheart.00166.2007","article-title":"Tumor necrosis factor-alpha is toxic via receptor 1 and protective via receptor 2 in a murine model of myocardial infarction","volume":"293","author":"Monden","year":"2007","journal-title":"Am J Physiol Heart Circ Physiol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00005792-201812140-00031","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T20:59:08Z","timestamp":1694725148000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201812140-00031"}},"subtitle":["Evidence from case\u2013control studies"],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":32,"journal-issue":{"issue":"50","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000013386","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12]]}}}